Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 5
2013 5
2014 2
2015 1
2016 4
2017 2
2018 3
2019 5
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Association between the risks of contrast-induced nephropathy after diagnostic or interventional coronary management and the transradial and transfemoral access approaches.
Firouzi A, Alemzadeh-Ansari MJ, Mohammadhadi N, Peighambari MM, Zahedmehr A, Mohebbi B, Kiani R, Sanati HR, Shakerian F, Rashidinejad A, Ghadrdoost B, Asghari R, Shokrollahi Yancheshmeh S. Firouzi A, et al. Among authors: sanati hr. J Cardiovasc Thorac Res. 2020;12(1):51-55. doi: 10.34172/jcvtr.2020.08. Epub 2020 Feb 12. J Cardiovasc Thorac Res. 2020. PMID: 32211138 Free PMC article.
Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.
Marashizadeh A, Sanati HR, Sadeghipour P, Peighambari MM, Moosavi J, Shafe O, Firouzi A, Zahedmehr A, Maadani M, Shakerian F, Kiani R, Mohebbi B, Alemzadeh-Ansari MJ, Tahvili R, Naghavi B. Marashizadeh A, et al. Among authors: sanati hr. Int Urol Nephrol. 2019 Oct;51(10):1815-1822. doi: 10.1007/s11255-019-02235-w. Epub 2019 Jul 22. Int Urol Nephrol. 2019. PMID: 31332700 Clinical Trial.
Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention.
Firouzi A, Kazem Moussavi A, Mohebbi A, Alemzadeh-Ansari MJ, Kiani R, Sanati HR, Mohebbi B, Shakerian F, Zahedmehr A, Ansari-Ramandi MM, Oni Heris S, Ghaleshi B, Ghorbani F. Firouzi A, et al. Among authors: sanati hr. J Cardiovasc Thorac Res. 2018;10(3):149-152. doi: 10.15171/jcvtr.2018.24. Epub 2018 Sep 24. J Cardiovasc Thorac Res. 2018. PMID: 30386535 Free PMC article.
27 results